Multiple Sclerosis Clinical Trials in Missouri

15 recruiting studies across 1 city

Browse by City

All Trials in Missouri

Phase

Trial	Phase	Sponsor	Dist.
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO	Phase 1	National Cancer Institute (NCI)	<1 mi
TSC Biosample Repository and Natural History Database	—	National Tuberous Sclerosis Association	<1 mi
Comparison Between ABP 692 and Ocrevus® (Ocrelizumab)	Phase 3	Amgen	3 mi
A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis	Phase 3	Novartis Pharmaceuticals	3 mi
Treatment of Participants With Primary or Secondary Progressive Multiple Sclerosis	Phase 1/2	Tr1X, Inc.	3 mi
Efficacy and Safety of Remibrutinib After Switching From Ocrelizumab in Participants Living With Relapsing Multiple Sclerosis.	Phase 3	Novartis Pharmaceuticals	3 mi
Efficacy of Cognitive Behavioral Therapy for Insomnia to Treat Insomnia Symptoms in Individuals With Multiple Sclerosis	Phase 2	University of Kansas Medical Center	3 mi
Dry Needling in Multiple Sclerosis	N/A	University of Kansas Medical Center	3 mi
AMT-260 Gene Therapy Study in Adults With Unilateral Refractory Mesial Temporal Lobe Epilepsy	Phase 1/2	UniQure Biopharma B.V.	3 mi
User-friendliness of a Portable Driving Simulator	N/A	University of Kansas Medical Center	3 mi
Comparing Telehealth-Delivered CBT-I to Web-Based CBT-I to Enhance Sleep, Reduce Fatigue, and Promote Neuroprotection	Phase 2	University of Kansas Medical Center	3 mi
A Study to Evaluate the Efficacy, Safety and Tolerability of BMS-986368 in Participants With Multiple Sclerosis Spasticity	Phase 2	Celgene	3 mi
A Study to Evaluate the Safety, Tolerability, Efficacy, and Drug Levels of CC-97540 in Participants With Relapsing Forms of Multiple Sclerosis, Progressive Forms of Multiple Sclerosis or Refractory Myasthenia Gravis (MG) (Breakfree-2)	Phase 1	Juno Therapeutics, Inc., a Bristol-Myers Squibb Company	3 mi
RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses	Phase 2	Reunion Neuroscience Inc	3 mi
Study to Evaluate Safety, Efficacy and Pharmacokinetics (PK) of a Modified Regimen of Ublituximab	Phase 3	TG Therapeutics, Inc.	10 mi

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.